In the time it took you to type that, you could have called them yourselves. Why didn't you?
Johnny, been on this board long enough to have grown immune to these guys. Their efforts may affect price swings temporarily, but in the long run, they'll have no affect. View them as entertainment.
Going to take much more to push past 1.50. History and shorting has proven that. Perfect recipe of great potential blended with unimaginable buffoonery in the past, with a dash of recent hope makes this a stock that would normally spike with news like today's, but will continue to be viewed skeptically, IMO.
Gone is the three month hold between patient enrollment. This must be an indication of considerable success in Jordan, if results prompt FDA to allow expedited enrollment. This is very good.
Maybe, but reporters, in general, don't usually share their stories ahead of time. Kind of goes against the very nature of journalism.
Mike, how can "beyond safety" be assessed after 90 days, if "safety" can't be achieved "even after" Jordan's 1-year evaluation?
Doesn't add up with previous assertions that safety was achieved simply by Jordan surviving the implant surgery and, now (as far as we know) not experiencing any adverse affects, or degradation in condition beyond what might have been seen if no surgery were done at all. Yes, it's a marathon, but your characterization (while informed by your previous experience in this sector) seems to be making this particular marathon a 60-mile race, rather than a 26.2-miler.
Right. You've mentioned that. Just not sure the surgery and this supposed "feeling" coincides with the appropriate time needed for any potential (stressing potential) healing and reconnection of nerves. More likely phantom feelings.
I guess we longs would, by default, suggest you buy. After all, we're longs, and we must know something. All I know is this: Langer is brilliant. New management team is quiet, yes, but I attribute that to them actually working, doing the hard job of bringing brilliant science to market. Previous management was too busy cozying up to Boston Magazine to win Best Company to Work For awards. Frank missed the memo that pointed out that actually bringing a product to market has absolutely nothing to do with how great thirty-somethings find a company is to work for, with how to make it successful. Hype is hype. Work is work. And at least we're now in the latter, so that's good.
All that said, I once stood where you stood. I took the plunge, overbought, went (and am) deeply upside down, and yet after many many months of fear, doubt, nausea, panic, hope, joy, fear, and panic again, and lately...hope, the picture looks brighter than I've ever seen it. But, as your (our) go-to-wise-man-on-the-mountain Miker C said recently, when I put a similar question to him, he replied that..."we're a loooooong way away from this company" realizing it's dream (paraphrased), and that many hurdles (and possibly obstacles) lie ahead.
You should, however, also consult with our resident sad sack contrarian, Misanthrope. He's the true sage of this board, as his I-was-bullied-as-a-child negativity is consistently countered by a "strong buy" sentiment, which is always entertainingly funny, but at times does make you wonder.
But there is no documentation that Jordan felt anything anywhere, even though AlexSissy (aka Envy_Vo) says otherwise. Good luck, do your own DD, etc etc.
CNBC isn't much different. Social media has changed news...for the better. It has made us all journalists, able to report on anything we see/hear. Obviously absent is the editorial validity news agencies are supposed to provide, but in exchange, we get unfiltered information. In the case of Jordan, if I were to see tweets or a Facebook post, or an Instagram snap by him, his family, a doctor, or NVIV itself, I would find that more valid than a polished piece by Fox or CNBC. GLTU
KC, by local I meant the local Boston Fox channel. Good that the local AZ station aired a story, but nothing similar from the station that's just across the Charles from Cambridge. And your reference to Fox's coverage with Frank is (IMO) a black mark on them, as then was NOT the time to give NVIV air time, while now IS (and yet Fox did not). Maybe they don't want to be twice burned? I'm not a fan of TV NewserTainment in general. Probably due to my journalistic training, which at the time, was about the story, not what the story could be twisted into.
Good point. I do have a journalism background, and if you Google "Jordan Fallis Experimental" you'll see the "media frenzy" (as it was reported on Zachs), which starts and abruptly ends within a three day period between 11.11 and 11.14. News outlets are basically hoars (spelling error intentional) and will report on anything. So you would think this story had some teeth.
It is weird that the only news source was Fox (which, IMO, is the worst of the worst for legitimacy), and no one else picked it up. Not even Fox Boston, which you would think would like the local angle. I mean, they did, just today, post a piece titled "French Toast Crunch returns as cereal sales slide," which apparently trumps the possibility of a Cambridge biotech curing SCI paralysis.
I can only attribute this hard stop in coverage to two possibilities: 1. Gag order; 2. Deemed a "non story".
Nice to see Johnny Kabuki's contribution to the Jordan's Journey fund..I've not yet contributed, but will. We all should. Behind all this investment krap is a young kid fighting to get his previous life back, and a loving family dealing with a life changing event.
I did know that, and am not sure why I questioned it, other than brief confusion over "enrollment" in the trials vs the actual implantation. I was under the impression the multiple sites could be at-the-ready for a patient candidate, and accept that patient within the three months but not perform the surgery (ie, officially "enroll") until the 3-month all clear. Nonetheless, I have given myself a thumbs down for this post.
Read in NeuroNews that NVIV can not enroll a second patient until after the 3 month mark following implantation in first patient. This true? If so, that would make it likely no news will be forthcoming until mid January. Stock will likely be back around .75 by then, if you factor that this stock has a natural inclination to drop when there's no news, and even when there IS news. And with the erasure of all news coming out of the Fallis family and elsewhere, I'm sensing the NVIV train has again been derailed.
There is a black cloud hanging over this stock. You'd think momentum would be upwards, but this thing has disappointed so often in the past, it will likely take a true miracle to nudge this past 5 bucks. Kinda has the "burn me once, shame on you. Burn me twice, shame on me" thing going on. Long and hopeful, as always...
One thing I've realized during the Perrin Administration...Silence is good. Unlike his predecessor, Frankie "The Mouth" Reynolds, Perrin hunkers down, doesn't care about satisfying us nail-biting investors, and focuses on the job he was hired to execute. Good news will spike the price...natural fall will occur in days following, until it settles where it belongs. If next update is good, spike in price. Slight decline following the rise, then repeat again at next positive milestone. We may all be interjecting speculation on this board, which is fine, but I'm comforted (even during 7-10% retractions) that there's a good team at work behind the scenes.